Published:  Jul 28, 2016DOI: 10.7324/JAPS.2016.60728
Platelets are a prime reason for causing cardiovascular disease (CVD). After atherosclerotic plaque rupture, platelets can form pathogenic, formation of blood clot which leads to various cardiovascular events. The beneficial effect of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-Co-A) reductase inhibitors reduces CVDs clinically. The objective of this review is the pharmacological benefit of atorvastatin in CVD by platelets and plaque rupture due to high levels of cholesterol.
Natarajan P, Kanna S, Sahl S, Sathish P, Anand V. Pharmacological Effects of Atorvastatin In Platelet Function and Plaque Rupture. J App Pharm Sci, 2016; 6 (07): 189-192.
281 Absract views 7 PDF Downloads 288 Total views
Hypolipidemic activity and HPTLC analysis of Ixora coccinea L. LeavesNeelapu Neelima, Muvvala Sudhakar, Mrityunjaya B. Patil, B.V.S. Lakshmi
Formulation Development and Evaluation of Ticagrelor Tablet for Regulatory Market
Defining the role of bempedoic acid in lowering low-density lipoprotein cholesterolOleksii Korzh